ABSTRACT Three production trials and one nitrogen balance trial were conducted with Lohmann Brown hens to determine the requirement for and effects of an excess of isoleucine in layers at different ages (24 to 32 and 46 to 54 wk of age). The trials were designed as dose-response studies where isoleucine-deficient basal rations with 11.4 MJ metabolizable energy per kilogram were supplemented with varying amounts of L-isoleucine. In the production trials, dietary isoleucine concentrations ranged from 0.37 to 1.05%. In the three production trials, maximum daily egg mass was achieved at dietary isoleucine concentrations of between 0.39 and 0.75% (25 to 32 wk
INTRODUCTION
Ecological considerations have led to increasing efforts in laying hen nutrition to reduce dietary protein content and thus minimize emissions of nitrogen via the urine. In practical ration formulation a deficit of first-limiting amino acids can be prevented by supplying these amino acids in their free form. This applies particularly to the amino acids methionine, lysine and tryptophan. A progressive reduction of the dietary protein content can, however, lead to a situation where other amino acids, which are of no special concern in diets with normal protein levels, become limiting for performance. These include threonine and particularly the branched chain amino acids valine and isoleucine. Relatively few studies have been conducted to date on the isoleucine requirement of laying hens for optimum performance, and results often vary. In a study by Gous et al. (1987) maximum layer performance with a daily egg mass of 51 g and a BW of 1.9 kg was achieved at a daily isoleucine intake of 650 to 750 mg. McDonald and Morris (1985) estimated a dietary requirement of total isoleucine in the region of 588 to 708 mg to support a daily egg mass of 50 g and a 2002 Poultry Science Association, Inc. Received for publication January 29, 2002 . Accepted for publication June 24, 2002. 1 To whom correspondence should be addressed: eder@ landw.uni-halle.de.
1714
of age, daily egg mass 53 g), 0.40 and 0.57% (24 to 32 wk of age, daily egg mass 57 g), and 0.40 and 0.81% (46 to 54 wk of age, daily egg mass 56 g). The corresponding ranges of daily isoleucine intakes were 412 to 770 mg, 436 to 624 mg, and 431 to 874 mg. In the nitrogen balance trial, maximum total nitrogen retention was achieved at dietary isoleucine concentrations of between 0.43 and 0.57%. Dietary isoleucine concentrations higher than 0.8% caused a reduction in hen BW. Dietary isoleucine concentrations higher than 1.0% additionally caused a reduction in the daily egg mass. The study thus shows that the margin between requirement and excess of isoleucine is narrow in laying hens.
BW of 2.0 kg. In contrast, the requirement calculated by Harms and Russell (2000) in a recent study was considerably lower at 601 mg per day for a daily egg mass of 53 g. Huyghebaert et al. (1991) pointed out that the requirement to support the same daily egg mass differs among age categories due to variations in feed conversion. They estimated a requirement of 809 to 834 mg isoleucine per day between 32 and 36 wk of age to support a daily egg mass of 55 g and an approximately 15% higher requirement of 920 to 950 mg daily at 52 to 56 wk of age. Differences in the recommendations for a similar daily egg mass can be as high as 50%. The suggestion by the National Research Council (1994) of 715 mg isoleucine daily for brown-egg layers on 110 g of feed per hen lies in the middle of the requirement range experimentally determined by various authors.
In the case of branched chain amino acids the requirement for optimum performance is not the only consideration; tolerance for an excessive supply is also relevant. It has long been known from experiments in rats (Benton et al., 1956; Rogers et al., 1962) that antagonisms exist between the three branched chain amino acids. These antagonisms are due to the fact that in addition to sharing systems for transport through cellular membranes, these three amino acids are degraded by the same enzymes and also compete for transfer into the brain across the blood-brain barrier (Harper, 1984) . The performance-depressant effect of an excessive intake of leucine has been extensively studied, especially in rats (Harper et al., 1954; Sauberlich, 1961; Peng et al., 1973; Shinnick and Harper, 1977) . Less is known about the effects of an excessive supply of valine and isoleucine, especially in farm animals. In broilers the depressant effect on performance of an excessive intake of isoleucine has been demonstrated (Burnham et al., 1991) . In laying hens only studies on excess leucine are currently available. The tolerance of laying hens for elevated levels of valine and isoleucine is unknown.
The present study had a twofold objective: to make a further contribution to the estimation of the isoleucine requirement of laying hens and to evaluate the tolerance of laying hens for an excessive isoleucine supply. Doseresponse trials were designed in which an isoleucinedeficient basal diet was supplemented with variable amounts of L-isoleucine. The trials were conducted in different age categories to determine whether requirement and tolerance are affected by hen age.
MATERIALS AND METHODS
A total of four trials were conducted with Lohmann Brown laying hens. The first one, designed as a production trial, was conducted with hens at 25 wk of age and extended over eight weeks. A basal diet with a low isoleucine content of 0.39% was formulated (Table 1) . Seven diets were used, prepared from the basal diet by supplementation with varying amounts of L-isoleucine (Lohmann Animal Health, Cuxhaven, Germany, purity at least 98%). A wide range of isoleucine supplementation levels was chosen (0 to 0.42%) to determine both the requirement for isoleucine and the effects of an excess of isoleucine. The analyzed dietary isoleucine concentrations were 0.39, 0.45, 0.51, 0.57, 0.69, 0.75, and 0.81%.
The remaining trials (2, 3, and 4) were constructed based on the results of the first trial. In order to achieve a suboptimal isoleucine supply a basal diet was formulated with a lower isoleucine content than in the first experiment (Table 1) . The analyzed isoleucine concentration of this diet was 0.37%. Eight diets were prepared from the basal diet by adding varying amounts of L-isoleucine. At the lower concentrations (0.37 to 0.46%) smaller increments of supplemental isoleucine (about 0.03%) were chosen in order to accurately determine the isoleucine requirement. In the higher concentration range larger increments of supplemental isoleucine were chosen in order to cover as wide a range of isoleucine levels as possible. In order to determine the effects of excess isoleucine, the top range of the dietary isoleucine concentration was extended beyond the level of trial 1. The analyzed dietary isoleucine concentrations were 0. 37, 0.40, 0.43, 0.46, 0.51, 0.57, 0 .81 and 1.05%.
Trial 2 was designed as a production trial. It was conducted with laying hens at 24 wk of age and extended over nine weeks. Trial 3 was set up as a nitrogen balance trial with the aim of estimating the isoleucine requirement. In this trial only diets with isoleucine concentrations of between 0.37 and 0.57% were fed. It was conducted with laying hens at 29 wk of age. Trial 4 was a production experiment. The same diets were used as in Experiment 2, but the laying hens were older, at 46 wk of age. The trial extended over nine weeks.
The concentrations of the other essential amino acids in the diets were adjusted to conform with the recommendations of the German Nutrition Society (GfE, 1999) for laying hens. This was done by determining the concentrations of all amino acids in the various feedstuffs and supplementing individual amino acids as required. The analyzed concentrations of the amino acids in the diets are shown in Table 1 . Deviations of the analyzed amino acid contents from the intended values might mainly be due to analytical inaccuracies.
The treatment groups in the production trials each comprised 12 hens, the treatment groups in the balance trial each had six hens. The hens in all four trials were housed one bird per cage in an environmentally controlled room. The house temperature was 18 C. The room was lit for 14 h daily, the light intensity was 20 to 30 lx. Feed (in meal form) and water (via nipple drinkers) were available ad libitum. The first production trial extended over 8 wk; the duration of Trials 2 and 4 was 9 wk. The balance trial comprised a 5-d preliminary period and a 7-d collection period. All procedures followed established guidelines for the care and handling of animals and were approved by the veterinary council of Saxony-Anhalt.
The following data were recorded in the production trials: BW at the start and end of the trial, feed consumption weekly and number of eggs daily. The weight of each egg was determined weekly. In the first production trial egg quality parameters were evaluated additionally (albumen height, Haugh units).
In the nitrogen balance trial the following data were recorded daily: feed consumption, amount of excrement, number and weight of eggs. The egg contents were analyzed for amino acid composition. The productive protein value is defined as a percentage of the ratio between protein retained in egg and body and protein consumed in the diet.
The crude nutrient concentrations of the diets, excrements and eggs were analyzed according to official VDLUFA methods (Naumann and Bassler, 1976) . Concentrations of amino acids were determined by hydrolyzing diets and eggs with 6 N hydrochloric acid; the pH of the hydrolysate was adjusted to 2.20. Amino acids were separated and quantified by ion exchange chromatography in an amino acid analyzer.
2 A special separating column with cation exchanger resin (Eppendorf) was used for this purpose. Elution was performed with a gradient system consisting of four buffers of pH 3.40, 3.60, 4.50, and 11.0, and a standard buffer of pH 2.20. Detection took place following postcolumn derivatisation at a wavelength of 570 nm. The tryptophan concentration of the diets was determined by reverse-phase-HPLC. Separation took place on a RP-18-e column (5 µm, 250 × 4 mm), elution with a gradient of potassium dihydrogenphosphate (0.01 M, with 8% methanol) and methanol. Detection was by fluorescence at 280 nm (excitation) and 355 nm (emission).
Statistical analysis of the data was performed with STA-TISTICA for WINDOWS (StatSoft, Inc. 2000) . The data were tested for normal distribution and homogeneity of the variances. The data were evaluated by one-way analysis of variance. Where F-values were statistically significant (P < 0.05) the means were compared by the NEW-MAN-KEULS test. The range of optimum dietary isoleucine concentrations was determined by using the Saturation Kinetics Model according to Mercer et al. (1989) . This model was developed specifically for describing functions where an excess supply of a nutrient, after an initial rise followed by a plateau, results in a decline.
The N balance trial, whose sole purpose was to estimate the requirement, was evaluated by means of the following exponential model:
where y = response criteria, a = intercept (performance of the basal diet), b = maximum response due to increased isoleucine concentration, c = slope, d = isoleucine concentration of the basal diet and x = dietary isoleucine concentration of the treatment groups. We determined the isoleucine concentration at which 95% of the maximum performance increase was achieved, where x 95 = (ln 0.05/−c) Means within the same column lacking a common superscript are significantly different (P < 0.05).
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Results are means with n = 12 per treatment.
RESULTS
In the first trial, conducted with laying hens between 25 and 32 wk of age, no differences were observed in the major performance parameters (feed consumption, egg production, egg weight, daily egg mass) over a wide range of dietary isoleucine concentrations from 0.39 to 0.75% (Table 2) . At an isoleucine concentration of 0.81%, on the other hand, the parameters of feed consumption, egg production and daily egg mass were significantly lower than at isoleucine concentrations of 0.39 to 0.75%. At the 0.81% isoleucine level, the parameter egg weight was also significantly below the maximum, which occurred at an isoleucine concentration of 0.51%. Maximum BW increase was recorded between 0.39 and 0.69%. A further increase in the isoleucine concentration to 0.75 or 0.81% led to a marked BW loss.
The second trial, conducted with laying hens between 24 and 32 wk of age, largely confirmed the results of the first trial (Table 2 ). Daily egg mass showed its maximum at isoleucine concentrations between 0.40 and 0.57%, but declined significantly both at the lower isoleucine concentration of 0.37% and at the higher levels of 0.81 and 1.05%. The parameters of feed consumption, egg production, egg weight, feed conversion and BW change showed minimal differences, if any, at isoleucine concentrations between 0.37 and 0.81%. A significant deterioration of all analyzed traits was seen only at an isoleucine concentration of 1.05%. The Saturation Kinetics Model confirmed the wide range of optimal dietary isoleucine concentrations. According to this model, 99% of the maximum feed consumption was recorded at dietary isoleucine concentrations between 0.41 and 0.73% and 99% of the maximum daily egg mass at isoleucine concentrations between 0.42 and 0.73% (Figures 1 and 2) . Ninety-five percent of the maximum for feed consumption and daily egg mass was observed from 0.39 to 0.78% and from 0.39 to 0.79%, respectively.
The results of the nitrogen balance trial were in close agreement with those of the production trial (Table 3) . At a dietary isoleucine concentration of 0.37%, nitrogen intake, total nitrogen retention, nitrogen retention in egg, nitrogen retention in body and the productive protein value were distinctly below the maximum. Nitrogen retention in egg, nitrogen retention in body and productive protein value plateaued at isoleucine concentrations between 0.40 and 0.57%. Total nitrogen retention, on the other hand, only reached a plateau at a concentration of 0.43% isoleucine. According to an exponential function the isoleucine concentrations required to achieve 95% of maximum total nitrogen retention and productive protein value were 0.46 and 0.43%, respectively (Figures 3 and 4) .
The trial during the later part of the laying period (46 to 54 wk of age) produced similar results as those in the early laying period (Table 4) . At a dietary isoleucine concentration of 0.37%, egg weight and daily egg mass were up to 10% below their maximum, and plateaued at concentrations between 0.40 and 0.81% isoleucine. Feed consumption and egg production reached a plateau at isoleucine concentrations between 0.37 and 0.81%. At isoleucine concentrations of 1.05% feed consumption, egg production, egg weight and daily egg mass declined by up to 15% below their maximum. Feed conversion and BW change did not differ significantly at any of the analyzed isoleucine concentrations. The Saturation Kinetics Model confirmed the wide range of optimal dietary isoleucine concentrations. According to this model, 99% of the maximum feed consumption was recorded at dietary isoleucine concentrations between 0.43 and 0.75%, and 99% of the maximum daily egg mass at isoleucine concentrations between 0.42 and 0.78% (Figures 5 and 6 ). Ninetyfive percent of the maximum feed consumption and daily egg mass were achieved at concentrations in the range of 0.39 to 0.82 and 0.39 to 0.85%, respectively.
Haugh Units and albumen height were not affected either by a suboptimal or an excessive isoleucine intake (data not shown). The amino acid composition of the egg protein was also only slightly altered at a suboptimal isoleucine supply level (data not shown). The isoleucine concentration in the egg protein in particular was not affected by isoleucine intake. The percentage of isoleucine as a proportion of total amino acids in the egg content averaged 5.3% across all groups; the isoleucine concentration was 6.36 mg/g egg content, or 5.61 mg/g shell egg.
DISCUSSION
The isoleucine supplementation required for maximum daily egg mass was very similar among the three trials conducted in this study, irrespective of the age of the laying hens. In the first two trials, which were conducted at peak lay, maximum daily egg mass was achieved at daily isoleucine intakes ranging from 412 to 770 mg (Trial 1) and from 436 to 624 mg (Trial 2). In Trial 4, conducted with older hens, this range was between 431 and 874 mg. According to the mathematical regression model used, 95% to 99% of maximum daily egg mass was realized with a isoleucine intake of 416 and 472 mg/d, respectively. At this level of supplementation about 72% and 67% of the dietary isoleucine is transferred into the egg. This transfer rate is very high and shows that all the isoleucine in the ration was converted very efficiently. Huyghebaert et al. (1991) calculated a similarly high transfer rate of 70% in laying hens with an optimal isoleucine supply. The isoleucine requirement for optimum performance (95% or 99% of the maximum) found in the present study was distinctly lower than the suggestions of various authors Means within the same column lacking a common superscript are significantly different (P < 0.05).
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Results are means with n = 6 per treatment. (McDonald and Morris, 1985: 588 to 708 mg for a daily egg mass of 50 g; Harms and Russell, 2000 ; 601 mg for a daily egg mass of 53 g; Smith, 1978 ; 524 mg/d isoleucine for a daily egg mass of 45 g; Coon and Zhang, 1999 : 579 mg digestible isoleucine for a daily egg mass of 51 g) and also lower than the recommendations of the NRC (1994, 715 mg for brown laying hens with an egg production of 90%). One possible explanation for the low isoleucine requirement in this study compared with other studies might be the relatively short duration of the trial (8 to 9 wk), which means that BW was most affected by a suboptimal isoleucine supply. It is conceivable that given a longer experimental period, daily egg mass might also fall in response to a relatively low isoleucine intake of less than 500 mg/d. Moreover, the number of animals used per group was relatively small in the present study; consequently, variation of the results was relatively large, impeding statistical analysis. The requirement for isoleucine in the present study was almost identical in the two laying periods investigated (24 to 32 wk, 46 to 54 wk), with similar egg production and body mass. This indicates that the conversion efficiency of dietary isoleucine was similar in the two age groups. This observation is at odds with the study by Huyghebaert et al. (1991) , who observed a distinctly poorer conversion of isoleucine for egg formation in hens between 52 and 56 wk of age than between 32 to 36 wk of age. Assuming that the maintenance re- Means within the same column lacking a common superscript are significantly different (P < 0.05).
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quirement of laying hens for isoleucine is 67 mg/kg (McDonald and Morris, 1985) , the production requirement for the formation of a daily egg mass of 56 g was about 350 mg. Based on the analyzed isoleucine concentration of 5.61 mg/g shell egg, the calculated efficiency with which isoleucine is converted for egg formation is very high, at about 90%.
The study shows that a marked excess of isoleucine leads not only to a dose-dependent loss of BW, but also to a reduction in the daily egg mass. The depressant effect of isoleucine on performance may be due to antagonisms toward the other branched chain amino acids leucine and valine. These structurally similar amino acids utilize similar systems for transport through cellular membranes and use identical enzymes (branched chain amino transferases, branched chain α-keto acid dehydrogenase) for their degradation (Harper, 1984) . The competition from these amino acids for transfer into the brain across the blood-brain barrier probably plays a major role in the performance-depressant effect. In rats, an excess of leucine inhibited the transfer of valine, isoleucine and other large neutral amino acids (phenylalanine, tyrosine, histidine, methionine and tryptophan) from blood into the brain (Peng et al., 1973) . In broilers, diets with excessive levels of the three branched chain amino acids caused reduced concentrations of noradrenaline, dopamine and serotonin in the brain. This effect was due to lower levels of phenylalanine and tryptophan in the brain (Harrison and D'Mello, 1986 ). Serotonin particularly affects the feeding behavior of animals (Tackman et al., 1990; Mullen and Martin, 1992) . It can be assumed that a large excess of isoleucine also led to a reduced uptake of leucine and valine, as well as of other large neutral amino acids, from blood into the brain. The observation that hen BW was far more sensitive to an excess of isoleucine than to feed consumption suggests that excess isoleucine caused a deficiency of other amino acids, presumably valine and leucine, at the site of protein synthesis. This hypothesis is supported by the fact that supplementation with valine and isoleucine can considerably alleviate the depressant effect of excess leucine on performance (D'Mello and Lewis, 1970) . The observation that the synthesis of egg protein was less sensitive to a deficiency or excess of isoleucine than to the synthesis of body protein indicates the priority of egg protein synthesis. Synthesis of egg protein has priority over synthesis of body protein even in situations where amino acids are deficient, such as in methionine, lysine or phenylalanine deficiency (Chi and FIGURE 6 . Daily egg mass as a function of the dietary isoleucine concentration in Trial 4, as calculated by the Saturation Kinetics Model (Rmax = maximum daily egg mass). Speers, 1976; Jais et al., 1995) . It can be presumed that the effects of an excessive isoleucine supply on egg formation also depend on the duration of the experiment. An excessive intake of isoleucine over a prolonged period is likely to cause a greater reduction in egg formation.
The response of laying hens to an excess of isoleucine in this study was similar to that described for broilers (Burnham et al., 1991) . In broilers, too, the margin between optimum and excess is very narrow. The sensitivity of broilers to excess isoleucine can be reduced by raising the concentrations of leucine and valine (Burnham et al., 1991) . Although this aspect was not investigated in the present study, it can be presumed that in laying hens, too, tolerance for excess isoleucine can be increased by raising concentrations of leucine and valine.
The observation that albumen quality (albumen height, Haugh units) and the amino acid composition of the egg contents were affected only very slightly by the isoleucine supply was not surprising. Huyghebaert et al. (1991) also found that Haugh units were unaffected by the isoleucine supply. A modification in the amino acid profile of egg protein can only be achieved by altering the ratio of egg white to egg yolk, for example by a substantially varying the ratio of energy to crude protein in the diet (Kirchgeßner and Steinhart, 1981) . The calculated isoleucine concentration of 6.36 mg/g of total egg content agrees well with other data from the literature (Lunven et al., 1973; Scott et al., 1982) .
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